פוסט זה זמין גם ב: עברית
Sep 4, 2024
Contributor: Travis Barlock, MD
Educational Pearls:
-
SVT: supraventricular tachycardia
-
Pharmacotherapy for SVT includes drugs that block the AV node, such as adenosine
-
-
EKG criteria before adenosine administration in SVT
-
Regular rhythm
-
Monomorphic: all QRS complexes are identical
-
If the EKG is polymorphic, with QRS complexes displaying changing morphologies, it is unsafe to administer adenosine
-
Adenosine can worsen polymorphic VTach and lead to VFib
-
References
-
Ganz, Leonard I., and Peter L. Friedman. “Supraventricular Tachycardia.” New England Journal of Medicine, vol. 332, no. 3, 19 Jan. 1995, pp. 162–173, https://doi.org/10.1056/nejm199501193320307.
-
Smith JR, Goldberger JJ, Kadish AH. Adenosine induced polymorphic ventricular tachycardia in adults without structural heart disease. Pacing Clin Electrophysiol. 1997;20(3 Pt 1):743-745. doi:10.1111/j.1540-8159.1997.tb03897.x
-
Viskin, Sami, et al. “Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.” Circulation, vol. 144, no. 10, 7 Sept. 2021, pp. 823–839, https://doi.org/10.1161/circulationaha.121.055783.
Summarized by Meg Joyce, MS1 | Edited by Meg Joyce & Jorge Chalit, OMS3